Article
Forkhead Box Transcription Factors: Double-Edged Swords in Cancer
22 Mar 2022
Abstract excerpt
A plethora of treatment options exist for cancer therapeutics, but many are limited by side effects and either intrinsic or acquired resistance. The need for more effective targeted cancer treatment has led to the focus on forkhead box (FOX) transcription factors as possible drug targets. Forkhead factors such as FOXA1 and FOXM1 are involved in hormone regulation, immune system modulation, and disease progression...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
